08:00 , Dec 12, 2005 |  BioCentury  |  Finance

PIPE adventures

PIPE adventures Company Date Raised PIPE price per share 12/9 cls Chg Adolor (ADLR) 5/30/01 $60.0 $20.00 $14.06 -30% Investors in the pain company included The Sprout Group; OrbiMed Advisors; Lombard Odier; and BB Biotech...
07:00 , Aug 19, 2002 |  BioCentury  |  Finance

The venture PIPEs

When the public market shuts off, it's common to see the PIPE market heat up. One sign of the depth of this bear market is that it's inducing some VCs to play in the public...
07:00 , Aug 12, 2002 |  BC Extra  |  Financial News

Corixa raises $45 million

Immunotherapeutics company CRXA raised $45 million in a private placement of 7.3 million shares at $6.13. Investors also purchased 1.2 million five-year warrants at $0.125 per underlying share, which are exercisable at $6.13. The financing...
08:00 , Dec 16, 1996 |  BioCentury  |  Finance

Early (or late?) to the starting gate

Despite a whipsaw market, three bravehearts are attempting to sell IPOs. The list includes diagnostic developer Biosite Diagnostics; Coulter Pharmaceutical, a developer of lymphoma therapies; and Epix Medical Inc. (formerly Metasyn), a developer of imaging...
07:00 , Oct 21, 1996 |  BioCentury  |  Finance

Finding a window

TKTX's offering may have been buttressed by the speculation surrounding its competition with Amgen (AMGN) in EPO (see BioCentury Sept. 3) . TKTX priced at $15 and traded as high as $17.75 on its first...
07:00 , Sep 23, 1996 |  BioCentury  |  Emerging Company Profile

Coulter Pharmaceutical Inc.

Coulter Pharmaceutical Inc. Palo Alto, Calif. Technology: Antibody conjugates and peptide prodrugs Disease focus: Cancer Clinical status: Pivotal Phase II/III Founded: 1995 by InterWest Partners and Coulter Corp. Corporate partners: None University collaborators: Universite Catholique...
07:00 , Jul 15, 1996 |  BioCentury  |  Finance

Guilt by association

Last week's sell-off of bioscience stocks highlights the Street's blurred vision when dealing with the "tech" in "biotech". When Apple Computer's woes have a trickle down effect on its suppliers, selling Motorola shares may seem...